15 lakh pregnant women got HIV tests done during Covid in Rajasthan

JAIPUR: While a lot of family planning indicators have been affected due to Covid, screening for HIV in pregnant women has registered a growth during 2020-21.

The screening is done to prevent vertical transmission of the infection from an infected mother to the foetus. In 2020-21, the state reported 15.3 lakh HIV tests in pregnant women, up from 14.2 lakh in 2018-19 and 15.2 lakh in 2019-20.

“In 2020-21, we reported more HIV testing in pregnant women who come to hospitals for ante-natal care,” said Dr Ravi Prakash Sharma, director (AIDS).

Whenever a pregnant woman comes for the first antenatal check to any hospital, doctors encourage her to get HIV testing done, which is voluntary. “HIV testing is done to detect HIV in early stage. If a pregnant woman is HIV positive, chances are that the infection is transmitted to the foetus. If she tests positive for HIV, treatment is available which reduces the chances of vertical transmission of HIV from the infected mother to the newborn,” said a health department official.

The health department has provided access to HIV testing services to all pregnant women enrolled for antenatal care along with provision of ARV (Antiretroviral) prophylaxis with single dose of nevirapine at the time of delivery.

Officials said mother to child transmission of HIV is the primary route of transmission for HIV among children. Such transmission is known to occur during pregnancy, delivery and breast-feeding period with equal frequency. It is estimated that without any intervention the risk of transmission of HIV from infected mother to her child is between 20% to 45%.

  • Related Posts

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn bio sciences Inc, a leading patient-focused cell and gene therapy Contract Development and Manufacturing Organization (CDMO), has partnered with Queen’s University to develop and manufacture AAV9-GM2, a gene therapy…

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics Inc, a biologics company focused on developing, manufacturing and commercializing advanced human tissue-based products, announced the completion of its acquisition of the SimpliDerm hydrated human acellular dermal matrix…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Andelyn Biosciences partners with Queen’s University to develop and manufacture gene therapy AAV9-GM2 to treat GM2 gangliosidoses

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    Cellution Biologics completes acquisition of SimpliDerm business for US$ 8 million from Elutia

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    ACB Gujarat arrested two FDA Officials red-handed in Bharuch accepting a bribe of ₹40,000

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    US appeals court sides with Sun Pharma in Lipitor antitrust case

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Counterfeit Cosmetics Are No Longer a Fringe Problem: 4 in 10 Consumers Report Fake Products, Regulatory Silence Raises Serious Questions

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad

    Three arrested for illegal sale of mephentermine sulphate injections in Hyderabad